# Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)

> **NCT04455802** · PHASE3 · WITHDRAWN · sponsor: **Women and Infants Hospital of Rhode Island**

## Conditions studied

- Neonatal Opioid Withdrawal Syndrome

## Interventions

- **DRUG:** Buprenorphine or Placebo
- **DRUG:** Morphine or Placebo

## Key facts

- **NCT ID:** NCT04455802
- **Lead sponsor:** Women and Infants Hospital of Rhode Island
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-10-01
- **Primary completion:** 2021-05-17
- **Final completion:** 2021-05-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** termination of funding
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04455802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04455802, "Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04455802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*